Breast Cancer Stories from U-M Cancer Center

Key points
- his year, an estimated 178,000 women will hear their doctors say “You have breast cancer.
- Once Alyssa Tushman knew her young son would not grow up motherless, her next question was whether he would be an only child.
- Black women, women with less education, women with lower household incomes and obese women may be receiving inferior breast cancer care.
- Heather Jose was 26 when she was diagnosed with advanced breast cancer.
his year, an estimated 178,000 women will hear their doctors say “You have breast cancer.” More than 40,000 women will die from the disease.
As October marks Breast Cancer Awareness Month, here are some of the hot topics in breast cancer research and patient care from the University of Michigan Comprehensive Cancer Center:
Pregnancy after breast cancer
Once Alyssa Tushman knew her young son would not grow up motherless, her next question was whether he would be an only child.
Tushman was 27 and a new mother when she was diagnosed with stage III breast cancer. After aggressive treatment – including chemotherapy, radiation therapy, a double mastectomy and reconstructive surgery – Tushman was happy to learn that another baby would be possible. And today, she's pregnant with her third child.
Most women are in their 50s or older and thinking about grandchildren when they are diagnosed with breast cancer. But what about that increasing number of women in their 20s and 30s who are diagnosed at a point when they are dating, getting married and just starting their family?
Despite toxic chemotherapy regimens that can mess with ovarian function, it is possible – and safe – for many women to conceive after breast cancer treatment, U-M specialists say.
Disparities in breast cancer treatment
Black women, women with less education, women with lower household incomes and obese women may be receiving inferior breast cancer care. A series of studies have shown black women and women with less education are more likely to receive a nonstandard form of chemotherapy to treat their breast cancer. In addition, patients with a lower household income and less education are more likely to receive reduced doses of chemotherapy, as are severely obese women compared to lean women. Doctors calculate chemotherapy doses for each patient based on her height and weight.
"These study results suggest systemic differences in care stemming from factors that have nothing to do with the patient's cancer. Given other disparities in quality of care and persistent outcome disparities in breast cancer among black women and women of lower socioeconomic status, our studies suggest the need to identify opportunities to address and eliminate these disparities," says lead study author Jennifer Griggs, M.D., associate professor of internal medicine at the University of Michigan Medical School and a breast cancer specialist at the U-M Comprehensive Cancer Center.
'Every day I'm killing cancer'
Heather Jose was 26 when she was diagnosed with advanced breast cancer. Told by her doctor to "get her affairs in order," Jose promptly found a new doctor at U-M, one who was willing to help her fight. That was eight years ago. Today, Jose, 34, works to bring a message of empowerment and hope to other women with breast cancer while helping their doctors and nurses understand how important it is to engage their patients.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNeoadjuvant use of pertuzumab in HER2-positive breast cancer
Pertuzumab (trade name: Perjeta) is approved for two therapeutic indications. Its use in combination with trastuzumab and docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable…
4 December 2015
NewsPotential new therapy for triple-negative breast cancer shows promise in lab studies
Recent laboratory findings provide novel insight into potential new therapeutic approaches for triple-negative breast cancer, a particularly difficult to treat and aggressive form of the disease. In a recent study…
28 October 2015
NewsUGR scientists patent an effective drug for treating breast, colon, and skin cancers
Scientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in breast, colon, and skin cancers. The researchers have proved the anti-tumor effects of the drug on…
21 October 2015


